Warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance on Warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic.

Further information including advice for healthcare professionals and patients can be found on the MHRA website.